Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination

This study is ongoing, but not recruiting participants.

First Received: November 26, 2008 Last Updated: May 17, 2009 History of Changes

Sponsors and Collaborators:	The University of North Carolina, Chapel Hill Merck
Information provided by:	The University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:	NCT00799474

Purpose

This research focuses on men who have sex with men (MSM) who are at higher risk of anal cancer. The survey will evaluate their beliefs about anal and oral cancer, their knowledge about role of HPV infection in these cancers, and their knowledge of HPV vaccination and anal Pap smears. Approximately 12% of subjects will be HIV-positive.

Condition
Anus Neoplasms

Study Type:	Observational
Study Design:	Cohort, Cross-Sectional
Official Title:	Men's Beliefs About Associations Between HPV, Cancers, and HPV Vaccination

Resource links provided by NLM:

MedlinePlus related topics: Anal Cancer Cancer

U.S. FDA Resources

Further study details as provided by The University of North Carolina, Chapel Hill:

Primary Outcome Measures:

Willingness to receive the HPV vaccine [ Time Frame: at time of interview ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Awareness of HPV vaccine [ Time Frame: At time of interview ] [ Designated as safety issue: No ]
Knowledge of HPV [ Time Frame: At time of interview ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	600
Study Start Date:	December 2008
Estimated Study Completion Date:	February 2009
Primary Completion Date:	February 2009 (Final data collection date for primary outcome measure)

Detailed Description:

Little research has examined men's understanding of what causes anal and oral cancers and whether HPV vaccination can play a potential protective role. This research focuses on men who have sex with men (MSM) who are at notably elevated risk of anal cancer, and seeks to characterize their beliefs about anal and oral cancer, knowledge about the etiological role of HPV infection in these cancers, as well as their knowledge of HPV vaccination and anal Pap smears. We will also study heterosexual men.

Eligibility

Ages Eligible for Study:	18 Years to 59 Years
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	Yes
Sampling Method:	Non-Probability Sample

Study Population

Approximately 600 men (ages 18-59) who have agreed to participate in a periodic panel through the private survey company, Knowledge Networks.

Criteria

Inclusion Criteria:

male
aged 18-59
answered question about sexual orientation and defini

Exclusion Criteria:

none

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00799474

Sponsors and Collaborators

The University of North Carolina, Chapel Hill

Merck

Investigators

Principal Investigator:

Noel Brewer, PhD

The University of North Carolina at Chapel Hill, School of Public Health

More Information

No publications provided

Responsible Party:	The University of North Carolina at Chapel Hill, School of Public Health ( Noel Brewer, PhD )
Study ID Numbers:	Merck-558377
Study First Received:	November 26, 2008
Last Updated:	May 17, 2009
ClinicalTrials.gov Identifier:	NCT00799474 History of Changes
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Digestive System Neoplasms
Rectal Neoplasms
Gastrointestinal Diseases
Rectal Neoplasm
Intestinal Diseases
Anal Cancer
Rectal Diseases

Intestinal Neoplasms
Digestive System Diseases
Rectal Cancer
Gastrointestinal Neoplasms
Anus Neoplasms
Colorectal Neoplasms

Additional relevant MeSH terms:

Digestive System Neoplasms
Rectal Neoplasms
Gastrointestinal Diseases
Intestinal Diseases
Rectal Diseases
Intestinal Neoplasms
Neoplasms

Neoplasms by Site
Digestive System Diseases
Gastrointestinal Neoplasms
Anus Neoplasms
Anus Diseases
Colorectal Neoplasms

ClinicalTrials.gov processed this record on September 10, 2009